May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
Endophthalmitis Rate Following Intravitreal Injection Using Topical 2% Viscous Lidocaine Anesthesia
Author Affiliations & Notes
  • N. G. Anderson
    Southeastern Retina Associates, Knoxville, Tennessee
    Surgery, University of Tennessee Medical Center, Knoxville, Tennessee
  • B. Panasuk
    Southeastern Retina Associates, Knoxville, Tennessee
  • Footnotes
    Commercial Relationships N.G. Anderson, None; B. Panasuk, None.
  • Footnotes
    Support None.
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 678. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      N. G. Anderson, B. Panasuk; Endophthalmitis Rate Following Intravitreal Injection Using Topical 2% Viscous Lidocaine Anesthesia. Invest. Ophthalmol. Vis. Sci. 2007;48(13):678.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose:: To determine the endophthalmitis rate following intravitreal injection using topical 2% viscous lidocaine anesthesia.

Methods:: Retrospective chart review. The charts of all patients undergoing intravitreal injection between August 15, 2005 and October 15, 2006 were reviewed.

Results:: A total of 379 consecutive injections were performed on 188 patients during the study period. All patients underwent topical anesthesia with 2% viscous lidocaine (Roxane Laboratories, Columbus, Ohio). One-hundred twenty ranibizumab injections were performed. One-hundred nineteen pegaptanib injections were performed. Ninety-one triamcinolone acetodine injections were performed. Forty-nine bevacizumab injections were performed. No cases of endophthalmitis occurred during the study period.

Conclusions:: No cases of endopthalmitis occurred following intravitreal injection using topical 2% viscous lidocaine anesthesia. The endophthalmitis rate using topical viscous lidocaine anesthesia for intravitreal injection does not appear to be higher than rates reported using previously published anesthesia techniques.

Keywords: endophthalmitis • clinical (human) or epidemiologic studies: risk factor assessment • injection 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×